Search Results for "drug"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for drug. Results 2481 to 2490 of 2587 total matches.

The Viralizer For The Common Cold

   
The Medical Letter on Drugs and Therapeutics • Jan 27, 1989  (Issue 784)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Recently, full-page advertisements have appeared in the New York Times and other newspapers promoting the Viralizer (Viral Response Systems, Greenwich, CT), a heated nebulizer-sprayer device marketed for treatment of colds, sore throats, allergy and sinusitis symptoms. The device is available without a prescription for about $30 to $40.
Med Lett Drugs Ther. 1989 Jan 27;31(784):8 |  Show IntroductionHide Introduction

Pallidotomy for Parkinson's Disease

   
The Medical Letter on Drugs and Therapeutics • Dec 06, 1996  (Issue 989)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Ablation of the globus pallidus, an old treatment for Parkinsons disease, is being tried again, using more refined stereotactic techniques, improved brain imaging and new methods for recording neuronal activity (CW Olanow, Ann Neurol, 40:341, September 1996).
Med Lett Drugs Ther. 1996 Dec 6;38(989):107 |  Show IntroductionHide Introduction

Cosmetic Phalloplasty

   
The Medical Letter on Drugs and Therapeutics • May 24, 2004  (Issue 1183)
have occurred. Medical Letter consultants advise against them. 44 The Medical Letter ® On Drugs ...
Some patients may be asking healthcare providers about the surgical techniques to enlarge the penis that are widely promoted on the Internet. Phalloplasty was first used to treat traumatic or surgical amputation (for cancer), epispadias and Peyronie's disease (JP Yurkanin et al, J Urol 2001; 166:1769).
Med Lett Drugs Ther. 2004 May 24;46(1183):44 |  Show IntroductionHide Introduction

New Treatments for Keratoconus

   
The Medical Letter on Drugs and Therapeutics • May 30, 2011  (Issue 1365)
The Medical Letter® On Drugs and Therapeutics Volume 53 (Issue 1365) May 30, 2011 ...
Keratoconus is a fairly common, progressive, noninflammatory, corneal-thinning disorder in which the cornea has a conical shape. Rigid gas permeable (RGP) contact lenses or corneal transplantation are effective treatments, but intracorneal ring segments and collagen cross-linking procedures offer some new alternatives in the management of the disease.
Med Lett Drugs Ther. 2011 May 30;53(1365):43-4 |  Show IntroductionHide Introduction

COVID-19 Update: Novavax Vaccine Authorized for Adolescents 12-17 Years Old (online only)

   
The Medical Letter on Drugs and Therapeutics • Oct 03, 2022  (Issue 1660)
COVID-19 vaccine. Med Lett Drugs Ther 2022; 64:121. 3. FDA. Fact sheet for health care providers ...
The FDA has expanded its Emergency Use Authorization for the adjuvanted protein subunit COVID-19 vaccine manufactured by Novavax to include use of the vaccine as a two-dose primary series in adolescents 12-17 years old. The vaccine was authorized for primary immunization of adults in July 2022.
Med Lett Drugs Ther. 2022 Oct 3;64(1660):e160 |  Show IntroductionHide Introduction

In Brief: Alternatives to Mifepristone for Medication Abortion

   
The Medical Letter on Drugs and Therapeutics • Jun 26, 2023  (Issue 1679)
parasitic infections. DRUGS FOR HEAD LICE — Since most available pediculicides are not ovicidal ...
The possibility that use of mifepristone (Mifeprex, and generics) may be restricted has led to questions about alternatives for medication abortion.
Med Lett Drugs Ther. 2023 Jun 26;65(1679):102-3   doi:10.58347/tml.2023.1679d |  Show IntroductionHide Introduction

In Brief: Prevention of Measles

   
The Medical Letter on Drugs and Therapeutics • May 01, 2025  (Issue 5107)
— No antiviral drugs have been approved by the FDA for treatment or prevention of measles. The live-attenuated ...
According to the Centers for Disease Control (CDC), as of April 24 there have been 844 confirmed cases of measles in the US in 2025; 11% of cases have resulted in hospitalization and 3 patients have died. The majority of cases (96%) have been in unvaccinated persons or in those whose vaccination history was unknown
Med Lett Drugs Ther. 2025 May 1;67(5107):1   doi:10.58347/tml.2025.5107a |  Show IntroductionHide Introduction

Interferon Treatment of Genital Warts

   
The Medical Letter on Drugs and Therapeutics • Jul 15, 1988  (Issue 770)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Recombinant interferon alfa-2b (Intron A - Schering) was recently approved by the US Food and Drug Administration (FDA) for intralesional treatment of genital warts (condylomata acuminata). Interferon was previously available only for treatment of hairy-cell leukemia (Medical Letter, 28:78, 1986).
Med Lett Drugs Ther. 1988 Jul 15;30(770):70-2 |  Show IntroductionHide Introduction

Organ Donation for Transplantation

   
The Medical Letter on Drugs and Therapeutics • Jul 07, 1995  (Issue 952)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Since the last Medical Letter article on this subject (volume 25, page 54, 1983), transplantation of various organs has become routine, but problems of supply and demand have persisted. The United Network for Organ Sharing (UNOS), which has contracted with the federal government to maintain a list of patients waiting for transplantation and a registry of patients who have received an organ, reports that 18,251 patients received an organ transplant in 1994, and as of June 1995 more than 40,000 patients were waiting for one.
Med Lett Drugs Ther. 1995 Jul 7;37(952):60-2 |  Show IntroductionHide Introduction

MenQuadfi - A New Meningococcal (A, C, W, and Y) Vaccine

   
The Medical Letter on Drugs and Therapeutics • May 17, 2021  (Issue 1624)
serogroup B vaccination recommendations. Med Lett Drugs Ther 2020; 62:191. 5. CI Baccarini et al. Safety ...
The FDA has licensed MenQuadfi (Sanofi Pasteur), a quadrivalent polysaccharide conjugate vaccine that uses tetanus toxoid as a protein carrier, for prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y (MenACWY) in persons ≥2 years old.
Med Lett Drugs Ther. 2021 May 17;63(1624):78-80 |  Show IntroductionHide Introduction